Heron Therapeutics Inc (HRTX)

Operating Expenses

$28.14M

Quarterly · Period ending: · USD

HRTX logo

HRTX Operating Expenses

Latest reported$28.14M
HRTX Quarterly Operating Expenses ($300.00K → $28.14M)
High-resolution chart · PNG

HRTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
28,138,000
28,838,000
32,901,000
26,922,000
28,980,000
27,292,000
26,380,000
27,810,000
31,951,000
31,024,000
34,568,000
38,155,000
54,007,000
45,824,000
37,756,000
53,722,000
60,953,000
75,025,000
63,251,000
63,587,000
68,390,000
62,925,000
72,509,000
71,179,000
69,412,000
67,512,000
78,571,000
60,282,000
74,850,000
81,340,000
68,586,000
53,990,000
50,899,000
60,424,000
70,605,000
48,835,000
49,552,000
51,745,000
48,047,000
47,734,000
43,066,000
17,220,000
14,797,000
22,491,000
23,014,000
20,360,000
19,495,000
18,953,000
18,791,000
17,322,000
7,077,000
12,664,000
15,209,000
5,612,000
3,476,000
2,428,000
4,380,000
4,769,000
4,118,000
4,089,000
1,791,000
1,710,000
1,912,000
1,986,000
4,225,000
3,112,000
2,222,000
2,330,000
3,974,000
2,977,000
3,852,000
6,341,000
6,401,000
7,220,000
7,948,000
5,357,000
4,635,000
6,150,000
5,726,000
3,948,000
4,789,000
4,401,000
4,119,000
3,174,000
3,901,000
2,671,000
3,820,000
3,416,000
3,725,000
3,759,000
2,876,000
2,503,000
3,101,000
2,980,000
2,374,000
2,678,000
2,809,000
2,143,000
3,237,000
2,814,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.